Diagnostic value of alpha1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood

Pediatric Hematology and Oncology

Volumn 18, Issue 1, 2001, Pages 11-26

  Schneider, Dominik T ^a,b   Calaminus, Gabriele ^a   Göbel, Ulrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

hCG; AFP; Diagnosis; Review; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ANAMNESIS; ATAXIA TELANGIECTASIA; CANCER CHEMOTHERAPY; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GERM CELL TUMOR; HISTOLOGY; HORMONE SYNTHESIS; HUMAN; INFANT; LIVER DISEASE; LIVER TUMOR; METABOLIC DISORDER; NORMAL VALUE; PEDIATRICIAN; RADIOLOGY; REVIEW; TREATMENT PLANNING; TUMOR BIOPSY;

ALPHA-FETOPROTEINS; CHILD; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; ENDODERMAL SINUS TUMOR; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035152372     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101750059828     Document Type: Review

References (94)

1. Elevated alpha-fetoprotein in a neonate with a benign hemangioendothelioma of the liver
2. Prenatal aspects of giant fetal cranial haemangio-endothelioma
3. Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level
4. An infant autopsy case of ependymoblastoma with high serum alpha fetoprotein
5. Haemangioendothelioma in a preterm infant associated with highly elevated alpha-fetoprotein
6. Hepatic hemangioendothelioma of infancy associated with elevated alpha fetoprotein and catecholamine by-products
7. 12000 miles for parental reassurance
8. Synthesis of alpha-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus
9. Synthesis of serum albumin, prealbumin, alpha-foetoprotein, alpha-1-antitrypsin and transferrin by the human yolk sac
10. Carcinofetal antigens, I: Alpha-fetoprotein
11. Alpha-fetoprotein: A biomarker for pregnancy outcome
12. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age
13. Normal values of alpha-fetoprotein in neonates and infants
14. Alpha-fetoprotein (AFP) levels in normal children
15. Clinical significance of serum alpha-fetoprotein subfractionation in pediatric diseases
16. AFP isoforms and their clinical significance
17. Alpha 1 fetoprotein-determination in patients with liver diseases
18. Serum alpha-fetoprotein in nonneoplastic liver diseases
19. Study of serum prealbumin and serum alpha fetoprotein in cases of fulminant hepatic failure
20. Alpha-fetoprotein changes in the course of chronic hepatitis: Relation to bridging hepatic necrosis and hepatocellular carcinoma
21. Prognostic value of alpha-foetoprotein in fulminant hepatitis
22. Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis
23. Consequences of the delayed diagnosis of ataxia-telangiectasia
24. Ataxia telangiectasia in the British Isles: The clinical and laboratory features of 70 affected individuals
25. Tissue of origin of elevated alpha-fetoprotein in ataxia-telangiectasia
26. Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor
27. Hereditary persistence of alpha-fetoprotein
28. Hereditary persistence of alpha-fetoprotein
29. Hereditary persistence of alpha-fetoprotein: Case report and review of the literature
30. A G→A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP)
31. Serum tumour markers in renal failure
32. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma
33. Results of the HB-89 study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol
34. Liver tumors in neonates and very young infants: Diagnostic pitfalls and therapeutic problems
35. Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I
36. AFP-producing squamous cell carcinoma of the lung in an adolescent
37. Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma
38. A case of alpha-fetoprotein-producing gastric carcinoma with unique macroscopical configuration
39. Two cases of alpha-fetoprotein producing early gastric cancers
40. A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin: Immunohistochemical and biochemical studies
41. Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment
42. A case of bladder cancer producing alpha-fetoprotein (AFP)
43. Alpha-fetoprotein-producing esophageal adenocarcinoma: Report of a case
44. A cystic partially differentiated nephroblastoma producing alpha-fetoprotein
45. Enhanced liver metastatic potential of alpha-fetoprotein-producing human gastric carcinoma after carbon tetrachloride-induced liver damage in nude mice
46. Radioimmunoassay for carcinoembryonic antigen and alpha 1-fetoprotein in the qualitative evaluation of focal hepatic lesions in Japan
47. Teratomas in infancy and childhood
48. Germ cell tumours of childhood: Report of 170 cases including 59 pure and partial yolk-sac tumours
49. Alpha-fetoprotein-producing pancreatoblastoma: A case report
50. Pancreatoblastoma in children: Case report and review of the literature
51. A teratoid Wilms' tumor with raised serum alpha-fetoprotein level
52. An unusual renal tumor, associating nephroblastoma, nephroblastomatosis, teratoma, and cystic dysplasia with arterial hypertension and secretion of alpha-fetoprotein
53. Clinical use of HCG and hCG beta determinations
54. Comparison of human chorionic gonadotropin and pregnancy-specific beta 1-glycoprotein in nonpregnant patients undergoing hemodialysis
55. Reactivation of the alpha 1-fetoprotein synthesis in systemic lupus erythematosus
56. A new endocrinological and immunological syndrome in SLE: Elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens
57. Pure dysgerminoma of the ovary with elevated serum human chorionic gonadotropin: Diagnostic and therapeutic considerations
58. Evidence for free beta-subunit secretion in so-called human chorionic gonadotropin-positive seminoma
59. Prognostic factors in seminomas with special respect to hCG: Results of a prospective multicenter study
60. Large mononuclear cells in seminoma - An immunohistochemical analysis of 21 cases
61. Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin: Clinicopathologic analysis of four cases and a review of the literature
62. Histologic characteristics of gonadotropin-producing hepato-blastoma: A survey of seven cases from Japan
63. Germ cell tumors in childhood and adolescence
64. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
65. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors
66. The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors
67. False elevations of alpha-fetoprotein associated with liver dysfunction in germ cell tumors
68. Reversible increase in serum alpha-fetoprotein content associated with hepatic dysfunction during chemotherapy for seminoma
69. Mediastinal growing teratoma syndrome
70. Growing teratoma syndrome: Experience of a single institution
71. Growing teratoma syndrome
72. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma: Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology
73. Primary mediastinal germ cell tumors in children and adolescents: Results of the German Cooperative Protocols MAKEI 83/86, 89, and 96
74. Primary chemotherapy and conservative surgery for vaginal yolk-sac tumour
75. Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ)
76. Alpha-fetoprotein in infantile obstructive jaundice in comparison with the normal ranges
77. The pathogenesis of raised serum alpha-fetoprotein levels in amoebic and pyogenic hepatic abscesses
78. Serum alpha-fetoprotein in amoebic liver abscess
79. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications
80. Serum alpha fetoprotein (AFP) levels in normal infants
81. Evaluation of alpha-fetoprotein in early infancy
82. Efficiency of composite laboratory test in the diagnosis of liver malignancies
83. Carcinoembryonic antigen and alpha fetoprotein levels in retinoblastoma
84. Alpha-fetoprotein and human chorionic gonadotropin-producing lung cancer
85. Peptide hormones in liver cirrhosis and hepatocellular carcinoma
86. Human chorionic gonadotropin in primary liver carcinoma in adults: An immunohistochemical study
87. Osteogenic sarcoma producing human chorionic gonadotrophin: Case report with immunohistochemical studies
88. Significance of serum beta-hCG as a tumor marker for stomach carcinoma
89. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease
90. Gallbladder carcinoma producing human chorionic gonadotropin
91. Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism
92. Placental proteins and their subunits as tumor markers in prostatic carcinoma
93. Serum tumor markers in metastatic breast cancer and course of disease